Influenza Antiviral Prescribing Practices and the Influence of Rapid Testing Among Primary Care Providers in the US, 2009-2016
- PMID: 31205973
- PMCID: PMC6557305
- DOI: 10.1093/ofid/ofz192
Influenza Antiviral Prescribing Practices and the Influence of Rapid Testing Among Primary Care Providers in the US, 2009-2016
Abstract
Background: Early influenza antiviral treatment within 2 days of illness onset can reduce illness severity and duration. Reliance on low sensitivity rapid influenza diagnostic tests (RIDTs) to guide antiviral prescribing has been reported. We describe antiviral prescribing practices among primary care providers from a large surveillance network in the United States.
Methods: From 2009-2016, a network of 36 to 68 outpatient clinics per year collected respiratory specimens and clinical data for patients with influenza-like illness (ILI). Specimens were tested for influenza using polymerase chain reaction (PCR). We used multivariable logistic regression to assess factors influencing antiviral prescribing.
Results: Among 13 540 patients with ILI, 2766 (20%) were prescribed antivirals. In age groups recommended to receive empiric antiviral treatment for suspected influenza, 11% of children <2 years and 23% of adults ≥65 years received a prescription. Among 3681 patients with a positive PCR test for influenza, 40% tested negative by RIDT. In multivariable analysis, prescription receipt was strongly associated with a positive RIDT (adjusted odds ratio [aOR] 12, 95% CI 11-14) and symptom onset ≤2 days before visit (aOR 4.3, 95% CI 3.8-4.9). Antiviral prescribing was also more frequent among pediatric and private family practice clinics compared with community health centers (aOR 1.9, 95% CI 1.6-2.2, and 1.3, 95% CI 1.1-1.5, respectively).
Conclusion: Primary care providers were more likely to prescribe antivirals to patients with a positive RIDT, but antivirals were prescribed infrequently even to patients in high-risk age groups. Understanding patient and provider characteristics associated with antiviral prescribing is important for communicating treatment recommendations.
Keywords: antiviral treatment; influenza; neuraminidase inhibitors; primary care.
Figures


References
-
- Neuzil KM, Mellen BG, Wright PF, et al. . The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000; 342:225–31. - PubMed
-
- Thompson WW, Shay DK, Weintraub E, et al. . Influenza-associated hospitalizations in the United States. JAMA 2004; 292:1333–40. - PubMed
-
- Thompson WW, Shay DK, Weintraub E, et al. . Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179–86. - PubMed
-
- Dawood FS, Chaves SS, Perez A, et al. . Complications and associated bacterial coinfections among children hospitalized with seasonal or pandemic influenza, United States, 2003–2010. J Infect Dis 2014; 209: 686–94. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources